For generations, U.S. laboratories treated animal testing as an unquestioned prerequisite for new drugs and chemicals, even as the ethical toll mounted. Now, after centuries of routine cruelty, the ...

Tech advances already show a future of testing in which we might not have to suffer and die while waiting for systems that ...

Replacing animal testing with alternate methodologies in preclinical drug trials holds potential for the development of ...

The report compares India’s non-clinical drug approval framework with regulatory practices in the US, European Union, the UK ...

The US Food and Drug Administration (FDA) recently announced a strategic roadmap to phase out animal testing requirements for certain drug products, starting with monoclonal antibodies. This shift ...

Animal testing in Connecticut rakes in millions in federal dollars each year at colleges and universities but, the National Institutes of Health recently announced it is pivoting from using just ...

In 2019, the EPA called for a 30% decrease in animal testing by 2025, and a total phase-out by 2035. The agency under the ...

Well before a human receives the first dose of an experimental drug, it’s evaluated in an animal to test for toxicity. Monkeys are often chosen for their genetic similarities to humans, and safe ...

The U.S. Food and Drug Administration (FDA) recently announced it plans to phase out animal testing in the development of monoclonal antibody therapies and other drugs and biological products “with ...

The National Institutes of Health (NIH) is following in the FDA’s footsteps—away from animal testing. The NIH plans to establish a new office meant to develop nonanimal methods for biomedical research ...

The U.S. Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies and other drugs be tested on animals, saying in a news release that there ...

Carlin is a vice president at Pathway Policy Group and a veterinarian. Paragas is the CEO and founder of DVLP Medicines and a virologist. The Food and Drug Administration’s recent decision to phase ...